Celltrion Inc.: Leading Korea’s Biosimilar Boom with Strong Stock & Innovation
Celltrion Inc: Korea’s biotech leader driving affordable biosimilars and consignment services, boasting a 41.71 trillion KRW market cap and strong investor confidence.
3 minutes to read